SB 446

  • Hawaii Senate Bill
  • 2024 Regular Session
  • Introduced in Senate Jan 20, 2023
  • Senate
  • House
  • Governor

Relating To Prescription Digital Therapeutics.

Abstract

Requires the Department of Health to conduct a study to determine the feasibility of implementing a pilot program to integrate prescription digital therapeutic products approved by the federal Food and Drug Administration in outpatient treatment programs for persons with substance use disorder and persons with opioid use disorder in the State. Requires a report to the Legislature. Effective 12/31/2050. (SD1)

Bill Sponsors (6)

Votes


Actions


Dec 11, 2023

Hawaii State Legislature

Carried over to 2024 Regular Session.

Feb 17, 2023

Senate

Report adopted; Passed Second Reading, as amended (SD 1) and referred to WAM.

  • Reading-2
  • Referral-Committee
Ways and Means

Senate

Reported from HHS (Stand. Com. Rep. No. 459) with recommendation of passage on Second Reading, as amended (SD 1) and referral to WAM.

Feb 06, 2023

Senate

The committee(s) on HHS recommend(s) that the measure be PASSED, WITH AMENDMENTS. The votes in HHS were as follows: 4 Aye(s): Senator(s) San Buenaventura, Aquino, Moriwaki, Shimabukuro; Aye(s) with reservations: none ; 1 No(es): Senator(s) Awa; and 0 Excused: none.

Feb 03, 2023

Senate

The committee(s) on HHS has scheduled a public hearing on 02-06-23 1:00PM; Conference Room 225 & Videoconference.

Jan 25, 2023

Senate

Referred to HHS, WAM.

  • Referral-Committee
Health and Human Services Ways and Means

Jan 20, 2023

Senate

Passed First Reading.

Senate

Introduced.

Bill Text

Bill Text Versions Format
SB446 PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Hawaii State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.